Found 15 matching trials
Low-Dose Tenecteplase in Covid-19 Diagnosed With Pulmonary Embolism PHASE4 * There is a knowledge gap associated with the management of patients with ...
Show More Location
Cedars-Sinai Medical Center
Learn More & Join Trial
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery PHASE3 The primary objective was to compare the efficacy of once daily \[q.d\] sub...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
A Study Comparing the Local Tolerability of Two Subcutaneous Heparins in Healthy Volunteers. PHASE4 A Phase IV, Randomised, Double-blind, Single-centre clinical trial in healt...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparison of Anticoagulation Prolongation vs. no Anticoagulation in STEMI Patients After Primary PCI PHASE4 The RIGHT study is a large randomized study dedicated to post-PPCI anticoag...
Show More Location
Beijing Anzhen Hospital, Capital Medical University
Learn More & Join Trial
Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery PHASE2 The primary objective was to demonstrate the dose-response of Semuloparin s...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement. PHASE3 The purpose of this study is to assess if 10 mg BAY59-7939, taken once dail...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery PHASE3 The primary objective was to compare the efficacy of Semuloparin sodium (AV...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery PHASE3 The primary objective was to compare the efficacy of once daily \[q.d.\] su...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
The SYMPTOMS - SYstematic Elderly Medical Patients Thromboprophylaxis: Efficacy on Symptomatic OutcoMeS - Study PHASE3 Venous thromboembolism (VTE) is a frequent condition, affecting 1.8 per 1,0...
Show More Location
Centre Hospitalier d'Agen
Learn More & Join Trial
Dose-ranging Study of Once-daily Regimen of BAY 59-7939 in the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement PHASE2 The purpose of this study is to assess different doses of a new drug (BAY 5...
Show More Location
Multiple Locations
Learn More & Join Trial